ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

IGX Intelgenx Technologies Corp

0,24
0,00 (0,00%)
Zuletzt aktualisiert: 15:30:02
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Intelgenx Technologies Corp IGX Toronto Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,24 15:30:02
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,24
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.6.202414:52GLOBEIntelGenx Announces Initiation of the Sale and Investment..
28.5.202416:05GLOBEIntelGenx Obtains Court-Approval of a Sale and Investment..
17.5.202423:39GLOBEIntelGenx Initiates Restructuring Proceedings Under the CCAA..
17.5.202416:04GLOBEIntelGenx Initiates Restructuring Proceedings Under the CCAA..
17.5.202415:18PRNCASuspension de la négociation par l'Organisme canadien de..
17.5.202415:13PRNCACanadian Investment Regulatory Organization Trading Halt -..
08.5.202413:45GLOBEIntelGenx Announces Voting Results on Election of Directors
08.4.202413:45GLOBEIntelGenx Announces First Parkinson’s Disease Patients Dosed..
05.4.202413:45GLOBEIntelGenx Updates Status of Buprenorphine Buccal Film ANDA
21.3.202412:30GLOBEIntelGenx Reports Fourth Quarter and Full-Year 2023..
14.3.202421:30GLOBEIntelGenx to Report Fourth Quarter and Full Year 2023..
11.3.202412:45GLOBEIntelGenx Enters Into a Third Amended and Restated Loan..
20.2.202416:50GLOBEUPDATE -- IntelGenx Launches Preferred Share Regulation A..
20.2.202413:50GLOBEIntelGenx Launches Preferred Share Regulation A Offering
05.2.202414:00GLOBEStudies Validate Advantages of Administering Drugs to Pets..
18.12.202313:15GLOBEIntelGenx Announces New Animal Health Partnership; Enters..
05.12.202314:00GLOBEIntelGenx Announces Closing of Previously Announced..
04.12.202314:00GLOBEIntelGenx Announces Changes to its Board of Directors
28.11.202322:05GLOBEIntelGenx Announces Shareholder Approval of Financing..
14.11.202313:30GLOBEIntelGenx Receives Approval to Conduct ’MONTPARK’..
13.11.202314:00GLOBEIntelGenx Reminds Shareholders to Vote at Upcoming Special..
09.11.202322:05GLOBEIntelGenx Reports Third Quarter 2023 Financial Results
06.11.202314:30GLOBEIntelGenx Announces Co-development and Commercialization of..
02.11.202321:45GLOBEIntelGenx to Report Third Quarter 2023 Financial Results on..
21.9.202314:00GLOBEIntelGenx Provides RIZAFILM® U.S. Commercialization Update
19.9.202314:00GLOBEIntelGenx Provides Regulatory Update for Xiromed-Partnered..
31.8.202314:30GLOBEIntelGenx Announces Closing of First Tranche of Non-Brokered..
14.8.202322:03GLOBEIntelGenx Reports Second Quarter 2023 Financial Results
10.8.202322:30GLOBEIntelGenx Announces First Agreement for CDMO Packaging..
07.8.202322:30GLOBEIntelGenx to Report Second Quarter 2023 Financial Results on..
01.8.202314:00GLOBEIntelGenx Completes Enrollment for ‘BUENA’ Montelukast..
25.7.202314:00GLOBEIntelGenx Provides Update on Research Collaboration..
21.7.202322:30GLOBEIntelGenx Announces a Change to its Board of Directors
06.7.202322:30GLOBEIntelGenx Announces Voting Results on Election of Directors

Kürzlich von Ihnen besucht

Delayed Upgrade Clock